Hepatic Disorders

the term metabolic dysfunction-associated steatotic liver disease (MASLD) as a replacement term for the condition nonalcoholic fatty liver disease (NAFLD) and the term metabolic dysfunction-associated steatohepatitis (MASH) as a replacement term for nonalcoholic steatohepatitis (NASH). MASLD provides a non-stigmatizing description of the condition that occurs in conjunction with a cardiometabolic risk factor, rather than a diagnosis of exclusion. The new nomenclature and definition received wide support in an international consensus process that included content experts and patient advocates (1).